Cancer clinical trials in the region Occitanie
132 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04268121
Neuroendocrine tumor
Localized
CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Universitaire de Toulouse (Toulouse), CHU Amiens-Picardie (site sud) (Amiens), Centre Hospitalier Universitaire de Besançon (Besançon) (and 4 more...)
Phase 2
Breast cancer
#NCT04143711
HER2 Low
HER2 Positive
Locally Advanced
Metastatic
Targeted therapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Breast cancer
#NCT04143711
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Lung cancer
#NCT04143711
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
HER2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Lung cancer
#NCT04042558
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
EGFR
ALK
ROS-1
Chemotherapy
Targeted therapy
Radiotherapy
Targeted therapy
Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Centre François Baclesse (Caen ), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Centre Hospitalier Universitaire de Grenoble (La Tronche) (and 13 more...)
Centre François Baclesse
Phase 2
Lymphoma
#NCT03703050
T cell lymphoma
Peripheral T cell lymphoma
Chemotherapy
Targeted therapy
Antibody Drug Conjugates (ADC)
1
Systemic Treatment-Naive
Hôpital Claude Huriez (Lille), Gustave Roussy (Villejuif), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Léon Bérard (Lyon), IUCT Oncopôle (Toulouse) (and 5 more...)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 2
Breast cancer
#NCT03475953
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Systemic Treatment-Naive
Immunotherapy
Bispecific T-cell engager antibodies
Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon), Institut du cancer de Montpellier (Montpellier), Institut Curie - Paris (Paris), Gustave Roussy (Villejuif) (and 2 more...)
Institut Bergonié
Phase 2
Lung cancer
#NCT03475953
NSCLC (Non-Small Cell Lung Cancer)
Mesothelium
Non-squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Antibody Drug Conjugates (ADC)
EGFR
ALK
ROS-1
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Institut du cancer de Montpellier (Montpellier), Institut Curie - Paris (Paris), Gustave Roussy (Villejuif) (and 2 more...)
Institut Bergonié
Phase 2
Prostate cancer
#NCT03438552
Adenocarcinoma
Biochemical recurrence
Radiotherapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Centre Oscar Lambret (Lille) (and 6 more...)
UNICANCER
Phase 2
Breast cancer
#NCT03424005
HER2 Low
HER2 Positive
HR Positive
Locally Advanced
Metastatic
PIK3CA
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse)
Hoffmann-La Roche